Research Analysts’ New Coverage for May 14th (ACU, ADMP, BCLI, BLIN, CASI, CLBS, CNCE, LFVN, NBRV, NEON)

Research Analysts’ new coverage for Saturday, May 14th:

StockNews.com initiated coverage on shares of Acme United (NYSE:ACU). StockNews.com issued a hold rating on the stock.

StockNews.com assumed coverage on shares of Adamis Pharmaceuticals (NASDAQ:ADMP). StockNews.com issued a sell rating on the stock.

StockNews.com began coverage on shares of Brainstorm Cell Therapeutics (NASDAQ:BCLI). They issued a hold rating on the stock.

StockNews.com began coverage on shares of Bridgeline Digital (NASDAQ:BLIN). They issued a hold rating on the stock.

StockNews.com initiated coverage on shares of CASI Pharmaceuticals (NASDAQ:CASI). They issued a hold rating on the stock.

StockNews.com started coverage on shares of Caladrius Biosciences (NASDAQ:CLBS). They issued a sell rating on the stock.

StockNews.com started coverage on shares of Concert Pharmaceuticals (NASDAQ:CNCE). They issued a hold rating on the stock.

StockNews.com assumed coverage on shares of LifeVantage (NASDAQ:LFVN). StockNews.com issued a buy rating on the stock.

StockNews.com initiated coverage on shares of Nabriva Therapeutics (NASDAQ:NBRV). The firm issued a hold rating on the stock.

StockNews.com assumed coverage on shares of Neonode (NASDAQ:NEON). StockNews.com issued a sell rating on the stock.

StockNews.com started coverage on shares of Relx (NYSE:RELX). StockNews.com issued a buy rating on the stock.

Receive News & Ratings for Acme United Co Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acme United Co and related companies with MarketBeat.com's FREE daily email newsletter.